AzTrials
AzTrials

Hip Impingement SyndromeNCT05720806

Weight Bearing Status Post-hip Arthroscopy

A study testing Weight Bearing as tolerated (WBAT) immediately following surgery. and Flat foot weight bearing (FFWB) immediately following surgery in people with Hip Impingement Syndrome and Acetabular Labral Tear, run by University of Pittsburgh at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Read more about this study

Who is it for?
Ages 12 to 65 years
What is being tested?
Weight Bearing as tolerated (WBAT) immediately following surgery. and Flat foot weight bearing (FFWB) immediately following surgery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteUnited States
Study dates
1 May 2023to 22 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Age>= 12 years
  • Diagnoses: femoroacetabular impingement and hip labral tears.
  • Surgical procedures performed: Hip arthroscopy with femoroplasty and labral repair.
  • Surgery completed at UPMC Children's or UPMC St. Margaret's Hospital
  • unilateral and bilateral hip patients

Who cannot join

  • MSK tumor-related FAI or dysplasia
  • generalized hypermobility
  • revision surgeries

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UPMC Hip Preservation Program

    Pittsburgh, Pennsylvania, 15238

Other trials in United States

About this study

Official title: Weight Bearing as Tolerated (WBAT) Following Hip Arthroscopic Labral Repair and Femoroplasty.

This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Cadaveric studies demonstrate that minimal force during weight bearing is distributed through labrum. Therefore, progressing weight bearing earlier in these patients post operatively may help progress faster and improve outcomes. Data collected will include demographic information, radiological data, operative procedures and PRO data.

Read the detailed description

The study will be conducted at UPMC St. Margaret's Hip Preservation Program. Consented patients who undergo acetabular labral repair and femoroplasty will be included in randomization of weight-bearing status. Two separate protocols will be created to indicate weight bearing status, either WBAT immediately post-op or FFWB immediately post-op, to distribute to rehabilitation staff to ensure compliance. Immediately after the surgical procedure, the surgeon will be blinded and a randomized pamphlet with post-operative instructions with weight bearing education will be given to PACU nursing staff to educate patients and fit crutches.

Being tested
Weight Bearing as tolerated (WBAT) immediately following surgery., Flat foot weight bearing (FFWB) immediately following surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Weight Bearing as tolerated (WBAT) immediately following surgery.Other

    Subject will be provided standard of care physical therapy following surgical intervention, except will be able to self-select weight bearing based on pain and confidence.

  • Flat foot weight bearing (FFWB) immediately following surgeryOther

    Subject will be provided standard of care physcial therapy following surgical intervention except

Study groups in NCT05720806
Study groupRoleWhat they receive
Weight bearing as tolerated (WBAT) immediately following surgery.ExperimentalSubjects will be able to self-select weight bearing based on pain and confidence in surgical hip.
Receives: Other: Weight Bearing as tolerated (WBAT) immediately following surgery.
Flat foot weight bearing (FFWB) for 2 weeks after surgery.Active comparatorSubjects will be limited to FFWB, approx 20lbs through the surgical hip.
Receives: Other: Flat foot weight bearing (FFWB) immediately following surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. International Hip Outcome Tool 12 (iHot-12)

    Scoring ranges from 0-100

    • each question is rated from 0-100 and final score is the mean of all questions answered by subject
    • higher scoring indicating higher quality of life due to hip function

    Measured: up to 6 months post-operative

  2. Hip and Groin Outcome Score (HAGOS)

    This outcome includes 6 subscales, these are scored independently, and no aggregate scoring is calculated as each section assesses different dimensions separately.

    Subscales (raw scores for each subscale converted to a 0-100 scale with higher score indicating higher level of function):

    • Pain
    • Symptoms
    • Activities of Daily Life
    • Function in Sport and recreation
    • Participation in Physical Activities
    • hip and groin-related quality of life

    Measured: up to 6 months post-operative

  3. Hip Outcome Score (HOS) ADL

    Outcome assessing function with activities of daily living. Higher score is given for higher level of function and lower score indicating reduced function.

    0-68 aggregate scoring converted to 0-100 scale.

    Measured: up to 6 months post-operative

  4. Hip Outcome Score (HOS) Sport

    Outcome assessing function/difficulty completing dynamic activities associated with sports participation. Higher score is given for higher level of function and lower score indicating reduced function.

    0-36 aggregate scoring converted to 0-100 scale.

    Measured: up to 6 months post-operative

  5. Tampa Scale for Kinesiophobia-11

    Outcome measure assessing fear of pain with movement. Scores range from 11 to 44. Higher scores indicate greater fear of movement

    Measured: up to 6 months post-operative

Secondary outcomes (4)
  1. Isometric strength measures hip add, abd, ER, and extension

    Strength measures will be taken isometrically at post-operative follow ups.

    Measured: 6-week, 3 months, and 6-month post-operative

  2. Diagnostic ultrasound assessment of bilateral anterior hip capsule thickness

    Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.

    Ultrasound will measure the following:

    1.Assess the bilateral hip anterior capsule in all patients, assessing for internal consistency or changes in capsular thickness from side to side. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm.

    Measured: 3 months post-operative

  3. Diagnostic ultrasound assessment of incision widening

    Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.

    1. Evaluation of capsular incision widening, cyst, attenuation and thinning from established norms. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm

    Measured: 3 months post-operative

  4. Diagnostic ultrasound for focal echogenic adhesions

    Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.

    1. Evaluate for focal echogenic adhesions or dyskinetic motion between capsule and overlying iliopsoas complex with activation of hip flexion.

    Measured: 3 months post-operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2023
  2. Study start1 May 2023
  3. Primary completion5 Dec 2025
  4. Study completion22 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects will be enrolled into either Weight bearing as tolerated group immediately or Flat foot weight bearing group for 2 weeks. Currently, flat foot weight bearing for the first 2 weeks is standard of care.
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05720806
Sponsor's protocol ID
STUDY22080053
Status last verified
Apr 2026
First submitted
10 Jan 2023
Last updated
13 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Weight Bearing as tolerated (WBAT) immediately following surgery. and Flat foot weight bearing (FFWB) immediately following surgery in people with Hip Impingement Syndrome and Acetabular Labral Tear, run by University of Pittsburgh at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

International Hip Outcome Tool 12 (iHot-12) (time frame: up to 6 months post-operative). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in